Related Experiment Video
Updated: Jan 13, 2026

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury
Published on: February 10, 2020
Bupivacaine exacerbates postoperative cognitive dysfunction by suppressing YES1-mediated YAP1 phosphorylation
1Department of Anesthesiology, Huai'an Hospital of Traditional Chinese Medicine, No. 3, Heping Road, Qingjiangpu District, Huai'an, 223001, Jiangsu, People's Republic of China.
Bupivacaine causes postoperative cognitive dysfunction (POCD) by reducing YES proto-oncogene 1 (YES1) and YAP1 phosphorylation, leading to DNA damage. Restoring YES1 may reverse these effects, offering potential therapeutic targets for POCD.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Bupivacaine is a widely used local anesthetic in human and equine medicine.
- Postoperative cognitive dysfunction (POCD) is a concerning complication following anesthesia and surgery.
- The precise molecular mechanisms underlying bupivacaine-induced POCD remain incompletely understood.
Purpose of the Study:
- To elucidate the molecular mechanism of bupivacaine-induced postoperative cognitive dysfunction (POCD).
- To investigate the role of YES proto-oncogene 1 (YES1) and Yes-associated protein 1 (YAP1) signaling in bupivacaine-induced POCD.
- To evaluate the therapeutic potential of targeting YES1/YAP1 signaling.
Main Methods:
- Development of a POCD mouse model using bupivacaine and surgery.
- Assessment of cognitive function using behavioral tests (Morris water maze, open field test, novel object recognition).
- Analysis of neuronal DNA damage and molecular signaling pathways (YES1, YAP1 phosphorylation) in both in vivo and in vitro models (SH-SY5Y cells).
- Pharmacological intervention using verteporfin, a YAP1 inhibitor.
Main Results:
- Bupivacaine administration impaired cognitive functions in mice, evidenced by increased escape latency, reduced platform crossings, decreased locomotion, and lower discrimination index.
- These cognitive deficits were associated with suppressed YES1 expression and reduced YAP1 phosphorylation in hippocampal tissues.
- YES1 overexpression ameliorated bupivacaine-induced POCD and neuronal DNA damage by enhancing YAP1 phosphorylation.
- Verteporfin treatment reversed the protective effects of YES1 overexpression and worsened POCD and DNA damage.
Conclusions:
- Bupivacaine induces POCD by suppressing YES1 expression and subsequent YAP1 phosphorylation, leading to neuronal DNA damage.
- Targeting the YES1/YAP1 pathway represents a promising therapeutic strategy for mitigating bupivacaine-induced cognitive impairment.
Related Concept Videos
Depolarizing Blockers: Pharmocokinetics
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Local Anesthetics: Mechanism of Action
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Local Anesthetics: Clinical Application as Spinal Anesthesia

